Concepedia

Deborah DeRyckere

DD

Statistics

Publications

51

Citations

3.1K

H-Index

32

Active since

1992

Affiliations

University of North Carolina at Chapel Hill(Current)

Children's Healthcare of Atlanta

Emory University

University of Colorado Anschutz Medical Campus

University of Colorado Denver

Deborah DeRyckere is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyTumor MicroenvironmentPharmacologyCancer ResearchImmunologyDrug DiscoveryCell SignalingRadiation Oncology

Publications per year

1992–2024

51

Publications

51

Structure and Function of Cdc6/Cdc18

Jinyu Liu, Cheryl L. Smith, Deborah DeRyckere et al. · Molecular Cell · 2000 · 229 citations

Structural Biology, Molecular Biology, Structural Bioinformatics

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer

Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings et al. · Oncogene · 2012 · 215 citations · Full text

Oncology, Medicine, Receptor Tyrosine Kinase +10

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

Rebecca S. Cook, Kristen M. Jacobsen, Anne Wofford et al. · Journal of Clinical Investigation · 2013 · 175 citations · Full text

Radiation Oncology, Mertk Expression, Cancer Immunosurveillance +13

<b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor

Weihe Zhang, Deborah DeRyckere, Debra M. Hunter et al. · Journal of Medicinal Chemistry · 2014 · 157 citations · Full text

Useful Selectivity, Pharmacotherapy, Pharmaceutical Chemistry +18

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Jennifer Schlegel, Maria J. Sambade, Susan Sather et al. · Journal of Clinical Investigation · 2013 · 142 citations · Full text

Mertk Expression, Skin Cancer, Medicine +11

1–5 of 51